# CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study

> **NCT00876512** · — · COMPLETED · sponsor: **Kumamoto University** · enrollment: 104 (actual)

## Conditions studied

- Stable Angina

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00876512
- **Lead sponsor:** Kumamoto University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2014-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876512, "CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00876512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*